Literature DB >> 33051200

Leukemoid reaction causing arterial thrombus in a patient with lung adenocarcinoma.

Zena Chahine1, Yazan Samhouri2, Thejus Jayakrishnan3, Dulabh Monga2.   

Abstract

A leukemoid reaction is typically defined as white blood cell (WBC) count >50×109/L, predominantly neutrophil precursors, that are not due to tumour involvement in the bone marrow and not derived from clones. Leukemoid reactions associated with malignancy, known as paraneoplastic leukemoid reactions, are less common and are most notably seen with non-small cell lung cancer. A 64-year-old woman presented with right leg painful ulceration. On examination, she had multiple venous stasis ulcers more severe on the right, with no palpable pulses in her lower extremities. Her WBC count was 124×109/L and platelets were 517×109/L. Arterial dopplers showed limb-threatening arterial insufficiency which prompted right femoral endarterectomy. Few months earlier she was diagnosed with metastatic lung adenocarcinoma to the bone and she had leukemoid reaction with WBC 43.920× 109/L with 90% neutrophils. Repeat imaging showed progression of her malignancy and she passed shortly after. Inflammation is a key element of carcinogenesis and cancer progression. Among the different tumours, lung cancer is a non-haematologic malignancy that is most closely associated with leucocytosis. Some studies have found that leucocytosis was significantly associated with metastasis and shorter survival irrespective of other factors such as age or sex. The mechanism remains unclear however elevated levels of granulocyte colony-stimulating factor (CSF), granulocyte macrophage-CSF and interleukin 6 have been linked to this phenomena. The degree of leucocytosis seen in our patient is suggestive of CSF production leading to a paraneoplastic leukemoid reaction. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (drugs and medicines); haematology (incl blood transfusion); lung cancer (oncology)

Mesh:

Year:  2020        PMID: 33051200      PMCID: PMC7554461          DOI: 10.1136/bcr-2020-235389

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Global patterns of cancer incidence and mortality rates and trends.

Authors:  Ahmedin Jemal; Melissa M Center; Carol DeSantis; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Role of smoking in global and regional cancer epidemiology: current patterns and data needs.

Authors:  Majid Ezzati; S Jane Henley; Alan D Lopez; Michael J Thun
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

3.  Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue.

Authors:  S Asano; A Urabe; T Okabe; N Sato; Y Kondo
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

4.  Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma.

Authors:  I Kasuga; S Makino; H Kiyokawa; H Katoh; Y Ebihara; K Ohyashiki
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

Review 5.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

6.  Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.

Authors:  Marie Wislez; Nathalie Rabbe; Joëlle Marchal; Bernard Milleron; Bruno Crestani; Charles Mayaud; Martine Antoine; Paul Soler; Jacques Cadranel
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.

Authors:  C L Sawyers; D W Golde; S Quan; S D Nimer
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

8.  Leukocytosis in non hematological malignancies--a possible tumor-associated marker.

Authors:  Y Shoenfeld; A Tal; S Berliner; J Pinkhas
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

9.  Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.

Authors:  John M Granger; Dimitrios P Kontoyiannis
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

10.  Leukemoid reaction in a patient with adenocarcinoma of the lung: a case report.

Authors:  Hendrik Riesenberg; Frauke Müller; Martin Görner
Journal:  J Med Case Rep       Date:  2012-07-19
View more
  1 in total

1.  Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis.

Authors:  Lindsey Sloan; Rakhi P Naik; Kavita Umrau; Rena Ruiyu Xian; Kristen A Marrone; Khinh Ranh Voong
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.